Sg Americas Securities, LLC Catalent, Inc. Transaction History

Sg Americas Securities, LLC

$27.6 Billion
Q3 2024

A detailed history of Sg Americas Securities, LLC transactions in Catalent, Inc. stock. As of the latest transaction made, Sg Americas Securities, LLC holds 20,203 shares of CTLT stock, worth $1.28 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

20,203

Previous 47,953 57.87%

Holding current value

$1.28 Million

Previous $2.7 Million 54.6%

% of portfolio

0.0%

Previous 0.02%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 03, 2024	SELL	$56.16 - $60.96 $1.56 Million - $1.69 Million	-27,750 Reduced 57.87%	20,203 $1.22 Million
Q2 2024 Jul 12, 2024	SELL	$53.58 - $57.02 $2.77 Million - $2.94 Million	-51,635 Reduced 51.85%	47,953 $2.7 Million
Q1 2024 May 06, 2024	BUY	$42.56 - $59.82 $2.53 Million - $3.55 Million	59,339 Added 147.43%	99,588 $5.62 Million
Q4 2023 Jan 12, 2024	BUY	$32.18 - $46.57 $914,233 - $1.32 Million	28,410 Added 239.97%	40,249 $1.81 Million
Q3 2023 Oct 13, 2023	SELL	$44.2 - $50.2 $331,809 - $376,851	-7,507 Reduced 38.8%	11,839 $539,000
Q2 2023 Jul 10, 2023	BUY	$31.86 - $67.26 $283,394 - $598,277	8,895 Added 85.11%	19,346 $839,000
Q1 2023 Apr 28, 2023	SELL	$45.44 - $74.26 $478,301 - $781,660	-10,526 Reduced 50.18%	10,451 $687,000
Q4 2022 Feb 02, 2023	BUY	$41.39 - $81.0 $406,946 - $796,392	9,832 Added 88.22%	20,977 $944,000
Q3 2022 Oct 31, 2022	BUY	$72.36 - $113.1 $573,380 - $896,204	7,924 Added 246.01%	11,145 $806,000
Q2 2022 Jul 29, 2022	SELL	$87.2 - $114.05 $52,581 - $68,772	-603 Reduced 15.77%	3,221 $346,000
Q1 2022 Apr 29, 2022	SELL	$94.19 - $124.49 $505,046 - $667,515	-5,362 Reduced 58.37%	3,824 $424,000
Q4 2021 Feb 07, 2022	BUY	$119.57 - $139.07 $669,113 - $778,235	5,596 Added 155.88%	9,186 $1.18 Million
Q3 2021 Nov 01, 2021	SELL	$109.17 - $142.35 $1.7 Million - $2.22 Million	-15,577 Reduced 81.27%	3,590 $478,000
Q2 2021 Aug 12, 2021	BUY	$100.34 - $115.69 $247,237 - $285,060	2,464 Added 14.75%	19,167 $2.07 Million
Q1 2021 May 13, 2021	SELL	$101.51 - $125.27 $819,287 - $1.01 Million	-8,071 Reduced 32.58%	16,703 $1.76 Million
Q4 2020 Feb 04, 2021	BUY	$85.88 - $105.36 $1.84 Million - $2.26 Million	21,440 Added 643.07%	24,774 $2.58 Million
Q3 2020 Nov 09, 2020	SELL	$72.74 - $92.5 $3.15 Million - $4.01 Million	-43,361 Reduced 92.86%	3,334 $286,000
Q2 2020 Jul 20, 2020	BUY	$48.02 - $79.04 $2.02 Million - $3.33 Million	42,095 Added 915.11%	46,695 $3.42 Million
Q1 2020 Apr 30, 2020	SELL	$36.95 - $62.95 $67,507 - $115,009	-1,827 Reduced 28.43%	4,600 $239,000
Q4 2019 Jan 28, 2020	SELL	$47.06 - $56.64 $1.39 Million - $1.68 Million	-29,583 Reduced 82.15%	6,427 $362,000
Q3 2019 Nov 04, 2019	BUY	$47.45 - $58.05 $433,835 - $530,751	9,143 Added 34.03%	36,010 $1.72 Million
Q2 2019 Jul 29, 2019	SELL	$39.26 - $54.21 $2.57 Million - $3.54 Million	-65,344 Reduced 70.86%	26,867 $1.46 Million
Q1 2019 Apr 29, 2019	BUY	$29.84 - $43.92 $2.59 Million - $3.81 Million	86,838 Added 1616.19%	92,211 $3.74 Million
Q4 2018 Feb 01, 2019	SELL	$29.95 - $46.34 $2.02 Million - $3.12 Million	-67,368 Reduced 92.61%	5,373 $168,000
Q3 2018 Nov 06, 2018	BUY	$40.12 - $45.55 $1.78 Million - $2.02 Million	44,313 Added 155.88%	72,741 $3.31 Million
Q2 2018 Aug 07, 2018	SELL	$38.72 - $42.52 $144,193 - $158,344	-3,724 Reduced 11.58%	28,428 $1.19 Million
Q1 2018 May 03, 2018	SELL	$39.4 - $47.39 $308,580 - $371,158	-7,832 Reduced 19.59%	32,152 $1.32 Million
Q4 2017 Jan 24, 2018	BUY	$37.27 - $43.02 $58,849 - $67,928	1,579 Added 4.11%	39,984 $1.64 Million
Q3 2017 Nov 07, 2017	BUY	$33.75 - $41.67 $1.3 Million - $1.6 Million	38,405	38,405 $1.53 Million

Others Institutions Holding CTLT

# of Institutions

514

Shares Held

149M

Call Options Held

575K

Put Options Held

2.03M

View Full List

About Catalent, Inc.

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

More about CTLT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Account

Sg Americas Securities, LLC Catalent, Inc. Transaction History